Home/Filings/4/0000899243-22-005942
4//SEC Filing

Bodenrader Mark 4

Accession 0000899243-22-005942

CIK 0001805387other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 6:47 PM ET

Size

5.6 KB

Accession

0000899243-22-005942

Insider Transaction Report

Form 4
Period: 2022-02-09
Bodenrader Mark
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-09+24,80024,800 total
    Exercise: $30.36Exp: 2032-02-09Common Stock (24,800 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest and become exercisable on February 9, 2023, with the remainder vesting in thirty-six (36) monthly installments thereafter.

Issuer

Cerevel Therapeutics Holdings, Inc.

CIK 0001805387

Entity typeother

Related Parties

1
  • filerCIK 0001830371

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 6:47 PM ET
Size
5.6 KB